Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 0 | 18,943 |
| Gross Profit | N/A | N/A | N/A | N/A | 18,943 |
| Operating Expenses | 241,648 | 196,919 | 191,089 | -144,648 | 86,897 |
| Operating Income | -241,648 | -196,919 | -191,089 | 144,648 | -67,954 |
| Other Income | 21,769 | 29,461 | 21,866 | 6,668 | 469 |
| Pre-tax Income | -219,879 | -167,458 | -169,223 | 151,316 | -67,485 |
| Income Tax | N/A | 117 | -14,122 | 42,121 | 0 |
| Net Income Continuous | -219,879 | -167,575 | -155,101 | 109,195 | -67,485 |
| Minority Interests | N/A | -192 | -1,939 | -2,019 | -1,915 |
| Net Income | $-219,879 | $-167,383 | $-153,162 | $111,214 | $-65,570 |
| EPS Basic Total Ops | -3.36 | -2.78 | -3.21 | 2.46 | -1.52 |
| EPS Basic Continuous Ops | -3.72 | -3.12 | -3.73 | 2.42 | -1.57 |
| EPS Diluted Total Ops | -3.36 | -2.78 | -3.21 | 2.38 | -1.52 |
| EPS Diluted Continuous Ops | -3.72 | -3.12 | -3.73 | 2.34 | -1.57 |
| EPS Diluted Before Non-Recurring Items | -3.36 | -2.78 | -3.69 | 2.38 | -1.52 |
| EBITDA(a) | $-241,337 | $-196,613 | $-190,779 | $144,741 | $-67,901 |